我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

辛伐他汀联合应用氨氯地平和替米沙坦对高血压病患者的降压作用及逆转高血压左室肥厚的效果

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2010年第4期
页码:
537-540
栏目:
临床研究
出版日期:
2010-06-10

文章信息/Info

Title:
Effects of simvastatin plus amlodipine and telmisartan in treatment of hypertension and left ventricular hypertrophy
作者:
赵连友1; 艾永飞1; 田刚2; 何争3; 姜馨4; 林可1; 黄金燕1
第四军医大学：1.附属唐都医院心内科，陕西 西安 710038，3.附属西京医院心内科, 陕西 西安 710032；2.西安交通大学第一附属医院心内科，陕西 西安 710061； 4.陕西省人民医院老年心血管内科， 陕西 西安 710068
Author(s):
ZHAO Lian-you1;  AI Yong-fei1;  TIAN Gang2;  HE Zheng3;  JIANG Xin4;  LIN Ke1;  HUANG Jin-yan1
1.Department of Cardiology, Tangdu Hospital, Xi’an 710038, Shaanxi, China, 3.Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, Shaanxi, China; 2.Department of Cardiology, First Affiliated Hospital, Xi’an Jiaotong
关键词:
高血压; 原发性; 左心室肥厚; 氨氯地平; 替米沙坦; 辛伐他汀
Keywords:
hypotension;  left ventricular hypertrophy;  amlodipine;  telmisartan;  simvastatin
分类号:
R972.4
DOI:
-
文献标识码:
A
摘要:
目的: 比较氨氯地平联合应用替米沙坦（氨+替组）及氨氯地平和替米沙坦联合应用辛伐他汀（氨+替+辛组）对高血压病患者血压及左室肥厚（LVH）的影响，探讨辛伐他汀逆转高血压病LVH的效果。方法： 将确诊的79例伴有LVH的高血压病患者随机分配到氨+替组（59例）和氨+替+辛组（20例）。治疗18个月后，观察两组患者心脏形态学、心脏功能及血压水平的变化。结果： ①氨+替组及氨+替+辛组高血压病患者经过治疗后，收缩压（SBP）、舒张压（DBP）、室间隔厚度（IVST）、左室后壁厚度（LVPWT）、左室质量（LVM）、左室质量指数（LVMI）与治疗前比较，均有显著性降低（均P<0.01）。②左室舒张早期二尖瓣血流峰速度(E)及晚期血流峰速度(A)比值(E/A)及左室射血分数(LVEF)值与治疗前比较有显著性增高（P<0.01）。③氨+替组和氨+替+辛组两组治疗后SBP、DBP差别无显著性差异，但两组间的IVST、LVPWT、LVM、LVMI的改变比较均有显著差异（P<0.05），氨+替+辛组对其降低作用的效果更明显。结论： 氨+替+辛组有更强的降压、逆转LVH及改善心功能的作用，提示辛伐他汀具有逆转高血压LVH及协同保护心脏的效果。
Abstract:
AIM: To compare the effect of amlodipine plus telmisartan and simvastatin plus amlodipine and telmisartan on blood pressure in patients with hypertension and left ventricular hypertrophy (LVH) and to explore the effect of simvastatin on LVH. METHODS: Seventy-nine cases of diagnosed LVH were randomly assigned to amlodipine+amiloride group (59 cases) and amlodipine+telmisartan+simvastatin group (20 cases). Eighteen months after treatment, cardiac morphology and function and blood pressure changes were observed in patients. RESULTS: After treatment, systolic blood pressure (SBP), diastolic blood pressure (DBP), interventricular septal thickness (IVST), left ventricular mass (LVM) and left ventricular mass index (LVMI) significantly decreased in both amlodipine+telmisartan group and amlodipine+telmisartan+simvastatin group (P<0.01). E/A ratio and EF values were significantly improved (P<0.01). After treatment, no significant difference was observed in SBP and DBP between groups (P>0.05). A significant difference was found in IVST, LVPWT, LVM and LVMI (P<0.05) between groups and the effect of amlodipine+telmisartan+simvastatin was more obvious. CONCLUSION: Compared with amlodipine plus telmisartan, combined administration of amlodipine+telmisartan+simvastatin is more effective in treating hypertension and reversing LVH, suggesting that simvastatin has the synergistic effect of reversing LVH and conferring cardiac protection.

参考文献/References

［1］Devereux RB, Alonso BR, Lutes EM, et al. Echocardiography assessment of left vent ricular hypertrophy: comparison to necropsy findigs［J］. Am J Cardiol Cardiol, 1986, 57(6):450-458.

［2］王静,段春林. 国人正常左室质量指数的探讨［J］. 中华心血管病志, 1996, 24(3):233.

［3］林文辉，王齐增，鹏万军，等．高血压病左室肥厚对房室性心率失常的影响［J］． 心脏杂志, 2008, 20(1):71-73.

［4］Messerli FH, Kettlhut R. Left ventricular hypertrophy: A pressure independent cardiovascular risk factor［J］. J Cardiovasc Pharmacol, 1993, 22(Suppl 1):S7-S13.

［5］Segerson NM, Wasmund SL, Daccarett M, et al. The acute effect of atriov entricular pacing on sympathetic nerve activity in patients with normal and depressed left ventricular function［J］. Am J Physiol Heart Cir Physiol, 2008, 295(3):H1076-H1080.

［6］于海波,韩雅玲,王祖禄,等. 替米沙坦降压疗效的临床研究［J］. 中国高血压杂志, 2004, 12(6):515-518.

［7］景晓娟,赵连友,章燕,等. 氨氯地平联合替米沙坦及复方盐酸阿米洛利治疗高血压和左室肥厚的效果及其与瘦素的关系［J］. 心脏杂志, 2009, 21(3):367-370,374.

［8］田建伟,赵连友,王士雯,等. 阿伐他汀对幼年大鼠心肌成纤维细胞增殖和胶原合成的影响及其意义［J］. 中华医学杂志, 2003, 83(2):118-122.

［9］ McFarlane SI, Muniyappa R, Francisco R, et al. Clinical review145: Pleiotropic effects ofstatins: lipid reduction and beyond［J].J Clin Endocrinol Metab, 2002, 87(4):1451-1458.

[10]赵连友,陈永清,郑强荪,等. 辛伐他汀对自发性高血压大鼠左心室肥厚的影响及与蛋白激酶B表达的关系［J］. 中华医学杂志, 2005, 85(19):1344-1347.

[11]van der Harst P, Groenewegen HC, Roks AJ, et al. Rosuvastatin attenuates angiotensin II-induced neointimal for-mation after stent implantation in the rat［J］. Coron Artery Dis, 2008, 19(1):47-53.

[12]Singh U, Devaraj S, Jialal I, et al. Comparison effect of atorvastatin(10 versus 80 mg) on biomarkers of inflamation and oxidative stress in subjects with metabolic syndrome［J］. Am J Cardiol, 2008, 102(3):321-325.

［13］Tziakas DN, Chalikias GK,Stakos DA, et al. Effect of statins on collagen type I degradation in patients with coronary artery disease and atrial fibrillation［J］. Am J Cardiol, 2008, 101(2):199-202.

备注/Memo

备注/Memo:
收稿日期：2010-03-20.基金项目：国家十一五科技支撑计划子课题资助项目(2006BAI01A03) 通讯作者：赵连友，主任医师，主要从事高血压发病机制及相关疾病防治研究Email:zhaolyfmmu@yahoo.com.cn
更新日期/Last Update: 2010-05-20